CSPCY vs TDHOY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CSPCY · CSPC PHARMACEUTICAL GROUP LIMITED UNSPON ADS EACH REP 4 ORD SHS$4.00 ▲ 0.63%
TDHOY · T&D Holdings (ADR)$14.45 ▼ 3.54%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CSPCY +7.2%
- TDHOY +34.0%
Head to head
| Metric | CSPCY | TDHOY |
|---|---|---|
| Price | $4.00 | $14.45 |
| Change today | ▲ 0.63% | ▼ 3.54% |
| Market cap | $14.54B | $14.54B |
| Return, 3 months | -13.0% | -3.0% |
| Return, year to date | -5.2% | +24.6% |
| Return, 1 year | +7.8% | +29.7% |
| P/E (TTM) | 10.8 | 14.9 |
| P/B | 2.0 | 1.4 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 4.21% | 2.91% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 37 | 39 |
| 30-day volatility | 37.1% | 35.6% |
| Max drawdown, 1 year | -38.5% | -20.6% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CSPCY is the largest of the group by market value.
- TDHOY has returned the most over the past year.
- CSPCY carries the lowest trailing P/E.
- CSPCY pays the highest dividend yield.
- TDHOY has been the calmest stock over the last 30 days.